medigraphic.com
ISSN 1659-1046 (Print)
Odovtos - International Journal of Dental Sciences

2022, Number 3

<< Back Next >>

Odovtos-Int J Dent Sc 2022; 24 (3)

Effectiveness of the Therapeutic Laser in the Syndrome of Dysfunction of the Temporomandibular Joint of Arthrogenic Origin

Castillo-Madrigal J, Pozos-Guillén A, Gordillo-Moscoso A

Language: English
References: 31
Page: 124-138
PDF size: 921.53 Kb.


ABSTRACT

Temporomandibular joint dysfunction syndrome (TMD), is a collective term characterized by symptoms involving chewing muscles, temporomandibular joint and orofacial structures. The efficacy of low intensity laser (LLLT) Gallium arsenide, in combination with a non-steroidal anti-inflammatory drug (NSAID) was evaluated. The main objective was to evaluate the maximum mouth opening without pain (ABM), arthralgia in the joint capsule through visual analog scale (VAS), laterality, protrusion, joint noises and count of tablets ingested per group. A controlled clinical trial (double-blind-randomized) was carried out in 30 subjects, who presented DTM of arthrogenic etiology; 5 applications of LLLT were made with wavelength of 810 nm, output optical power of 100-200 mw, emission PW=Pulsed (1-10,000Hz), dose of 10 jouls-cm², time of 1.44 minutes in mouth closed and with the mouth half open. One more follow-up appointment per month. There were two groups: experimental and control group, where different variables were analyzed (ABM, laterality, protrusion, VAS and sociodemographic). In the control group, a supposed LT application (not active) was made, for later comparison. Pain-free ABM was assessed in all appointments in addition to the other clinical parameters. Repeated measures analysis was performed with mixed models. Thirty patients were included of which 28 finished the treatment, two of them were lost during follow-up. The groups were similar in all their baseline variables. There were no statistically significant differences when applying the final multiple regression analysis, in the ABM, or in any other of the clinical parameters analyzed. LT was not effective in treating arthrogenic DTM.


REFERENCES

  1. Carvalho F.R., Barros R.Q., Gonçalves A.S.,Freitas P.M. Photobiomodulation therapyon the palliative care of temporomandibulardisorder and orofacial/cervical skull pain:study protocol for a randomized controlledclinical trial. Trials 2019; 20 (1): 200.

  2. Sousa D.F.M., Gonçalves M.L.L., Politti F.,et al. Photobiomodulation with simultaneoususe of red and infrared light emitting diodesin the treatment of temporomandibular disorder:study protocol for a randomized, controlledand double-blind clinical trial. Medicine(Baltimore) 2019; 98 (6): e14391.

  3. Xu G.Z., Jia J., Jin L., Li J.H., Wang Z.Y.,Cao D.Y. Low-level laser therapy for temporomandibulardisorders: A systematic reviewwith meta-analysis. Pain Res Manag 2018;2018: 4230583.

  4. Sayed N., Murugavel C., Gnanam A.Management of temporomandibular disorderswith low level laser therapy. J MaxillofacOral Surg 2014; 13 (4): 444-50.

  5. Denucci D.J., Dionne R.A., Dubner R. Identifyinga neurobiologic basis for drug therapyin DTMs. J Am Dent Assoc 1996; 127 (5):581-93.

  6. Masumi S., Kim Y.J., Clark G.T. The valueof maximum jaw motion measurements fordistinguishing between common temporomandibulardisorder subgroups. Oral SurgOral Med Oral Pathol Oral Radiol Endod2002; 93 (5): 552-9.

  7. Yuasa H., Kurita K.; Treatment Group onTemporomandibular Disorders. Randomizedclinical trial of primary treatment for temporomandibularjoint disk displacement withoutreduction and without osseous changes: acombination of NSAIDs and mouth-openingexercise versus no treatment. Oral Surg OralMed Oral Pathol Oral Radiol Endod 2001; 91(6): 671-5.

  8. Okeson J.P. Tratamiento de oclusión yafecciones temporomandibulares. España:Edición 5ta. ed. Mosby Elsevier; 2003.

  9. Costa S.A.P., Florezi G.P., Artes G.E., et al.The analgesic effect of photobiomodulationtherapy (830 nm) on the masticatory muscles:a randomized, double-blind study. Braz OralRes 2017; 31: e107.

  10. De Carli M.L., Guerra M.B., Nunes T.B., etal. Piroxicam and laser phototherapy in thetreatment of TMJ arthralgia: a double-blindrandomised controlled trial. J Oral Rehabil2013; 40 (3): 171-8.

  11. Leal de Godoy C.H., Motta L.J., Garcia E.J.,et al. Electromyographic evaluation of alow-level laser protocol for the treatment oftemporomandibular disorder: a randomized, controlled, blind trial. J Phys Ther Sci 2017; 29 (12): 2107-11.

  12. Mazzetto M.O., Hotta T.H., Pizzo R.C. Measurements of jaw movements and TMJ pain intensity in patients treated with GaAlAs laser. Braz Dent J 2010; 21 (4): 356-60.

  13. Machado B.C., Mazzetto M.O., Da Silva M.A., de Felício C.M. Effects of oral motor exercises and laser therapy on chronic temporomandibular disorders: a randomized study with follow-up. Lasers Med Sci 2016; 31 (5): 945-54.

  14. Tuner J., Hode L. The laser therapy handbook. Sweden: ed. Prima Books AB; 2004.

  15. Manaf T.A. Low-level laser therapy as a solution in the dental clinic: A review and case report. J Oral Laser Application 2007; 7: 65-73.

  16. Ferreira L.A., de Oliveira R.G., Guimarães J.P., Carvalho A.C., De Paula M.V. Laser acupuncture in patients with temporomandibular dysfunction: a randomized controlled trial. Lasers Med Sci 2013; 28 (6): 1549-58.

  17. Shukla D., Muthusekhar M.R. Efficacy of low-level laser therapy in temporomandibular disorders: A systematic review. Natl J Maxillofac Surg 2016; 7 (1): 62-6.

  18. Marini I., Gatto M.R., Bonetti G.A. Effects of superpulsed low-level laser therapy on temporomandibular joint pain. Clin J Pain 2010; 26 (7): 611-6.

  19. Panhoca V.H., Lizarelli R. de F., Nunez S.C., et al. Comparative clinical study of light analgesic effect on temporomandibular disorder (DTM) using red and infrared led therapy. Lasers MedSci 2015; 30 (2): 815-22.

  20. Demirkol N., Sari F., Bulbul M., Demirkol M., Simsek I., Usumez A. Effectiveness of occlusal splints and low-level laser therapy on myofascial pain. Lasers Med Sci 2015; 30 (3): 1007-12.

  21. Venancio R. de A., Camparis C.M., Lizarelli R. de F. Low intensity laser therapy in the treatment of temporomandibular disorders: a double-blind study. J Oral Rehabil 2005; 32 (11): 800-7.

  22. Madani A.S., Ahrari F., Nasiri F., Abtahi M., Tunér J. Low-level laser therapy for management of TMJ osteoarthritis. Cranio 2014; 32 (1): 38-44.

  23. Emshoff R., Bösch R., Pümpel E., Schöning H., Strobl H. Low-level laser therapy for treatment of temporomandibular joint pain: a double-blind and placebo-controlled trial. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 2008; 105 (4): 452-6.

  24. Chen J., Huang Z., Ge M., Gao M. Efficacy of low-level laser therapy in the treatment of DTMs: a meta-analysis of 14 randomised controlled trials. J Oral Rehabil 2015; 42 (4): 291-9.

  25. Shobha R., Narayanan V.S., Jagadish Pai. B.S., Jaishankar H.P., Jijin M.J. Low-level laser therapy: A novel therapeutic approach to temporomandibular disorder - A randomized, double-blinded, placebo-controlled trial. Indian J Dent Res 2017; 28 (4): 380-7.

  26. Chellappa D., Thirupathy M. Comparative efficacy of low-Level laser and TENS in the symptomatic relief of temporomandibularjoint disorders: A randomized clinical trial.Indian J Dent Res 2020; 31 (1): 42-7.

  27. Rezazadeh F., Hajian K., Shahidi S., PirooziS. Comparison of the effects of transcutaneouselectrical nerve stimulation and low-level lasertherapy on drug-resistant temporomandibulardisorders. J Dent (Shiraz) 2017; 18 (3): 187-92.

  28. Carrasco T.G., Guerisoli L.D., GuerisoliD.M., Mazzetto M.O. Evaluation of lowintensity laser therapy in myofascial painsyndrome. Cranio 2009; 27 (4): 243-7.

  29. Van den Berghe L.I., de Boever J.A., SchautteetH. Double-blind clinical study ofAttribution (BY-NC) - (BY) You must give appropriate credit, provide a link to the license, and indicate if changes weremade. You may do so in any reasonable manner, but not in any way that suggest the licensor endorses you or youruse. (NC) You may not use the material for commercial purposes.Piroxicam as adjuvant in the treatment of thepain and dysfunction of the temporomandibularjoints. Cranio 1986; 4 (4): 351-6.

  30. Khalighi H.R., Mortazavi H., Mojahedi S.M.,Azari-Marhabi S., Moradi Abbasabadi F.Low level laser therapy versus pharmacotherapyin improving myofascial pain disordersyndrome. J Lasers Med Sci 2016; 7 (1):45-50.

  31. Kaptchuk T.J., Goldman P., Stone D.A.,Stason W.B. ¿Do medical devices haveenhanced placebo effects? J Clin Epidemiol2000; 53: 786-92.




2020     |     www.medigraphic.com